Quest for the right Drug
טרמדקס טבליות TRAMADEX TABLETS (TRAMADOL HYDROCHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
טבליה : TABLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8. Undesirable effects The most commonly reported adverse reactions are nausea and dizziness, both occurring in more than 10 % of patients. The frequencies are defined as follows: Very common: ≥1/10 Common: ≥1/100, <1/10 Uncommon: ≥1/1000, <1/100 Rare: ≥1/10000, <1/1000 Very rare: <1/10000 Not known cannot be estimated from the available data Immune system disorders: Uncommon: toxic epidermal necrolysis (TEN) and Stevens-Johnson-syndrome (SJS), and cross reactivity with non-steroidal anti-inflammatory drugs Cardiovascular disorders: Common: hot flushes, vasodilation Uncommon: cardiovascular regulation (palpitation, tachycardia, postural hypotension or cardiovascular collapse). These adverse reactions may occur especially on intravenous administration and in patients who are physically stressed. Myocardial infarction, peripheral ischemia, hypertension, hypertension aggravated. Rare: bradycardia Nervous system disorders: Very common: dizziness/vertigo Common: headache, drowsiness, somnolence, hypoesthesia Uncommon: sedation, disturbance in attention, dizziness aggravated Rare: changes in appetite, paraesthesia, tremor, respiratory depression, epileptiform convulsions, involuntary muscle contractions, abnormal coordination, syncope, hypertonia and dysgeusia. If the recommended doses are considerably exceeded and other centrally depressant substances are administered concomitantly (see section 4.5), respiratory depression may occur. Epileptiform convulsions occurred mainly after administration of high doses of tramadol or after concomitant treatment with medicinal products which can lower the seizure threshold (see sections 4.4 and 4.5). Not known: speech disorders, abnormal gait, amnesia, difficulty in concentration, movement disorder, euphoria, emotional lability, delirium, paresthesia Psychiatric disorders: Common: depression, restlessness Uncommon: irritability, libido decreased, disorientation, abnormal dreams Rare: hallucinations, confusion, sleep disturbance, anxiety and nightmares. Psychic adverse reactions may occur following administration of Tramadex which vary individually in intensity and nature (depending on personality and duration of treatment). These include changes in mood (usually elation, occasionally dysphoria), changes in activity (usually suppression, occasionally increase) and changes in cognitive and sensorial capacity (e.g. decision behaviour, perception disorders). Dependence may occur. Suicidal ideation, drug abuse and addiction. Eye disorders: Common: miosis, visual disturbance Rare: blurred vision Not known: mydriasis Respiratory disorders: Common: sneezing, cough, rhinorrhea, nasal congestion, sinus congestion Uncommon: yawning Rare: dyspnoea. Worsening of asthma has been reported, though a causal relationship has not been established. Gastrointestinal disorders: Very common: nausea Common: constipation, dry mouth, vomiting, dyspepsia, abdominal pain Uncommon: anorexia, retching; gastrointestinal irritation (a feeling of pressure in the stomach, bloating), diarrhea, flatulence, toothache, constipation aggravated, appendicitis, pancreatitis Not known: sore throat Skin and subcutaneous tissue disorders: Common: sweating, dermatitis Uncommon: dermal reactions (e.g. pruritus, rash, urticaria), contusion, piloerection, clamminess, night sweats Not known: Vesicles Musculo-skeletal disorders: Common: arthralgia, back pain, pain in limb, neck pain Uncommon: muscle cramps, muscle spasms, joint stiffness, muscle twitching, myalgia, osteoarthritis aggravated Rare: motorial weakness Hepatobiliary disorders: Uncommon: cholelithiasis, cholecystitis Very rare: In a few isolated cases an increase in liver enzyme values has been reported in a temporal connection with the therapeutic use of tramadol. Renal and urinary disorders: Common: Urinary frequency Uncommon: hematuria Rare: micturition disorders (difficulty in passing urine, dysuria and urinary retention) Reproductive system and breast disorders: Common: menopausal symptoms Rare: menstrual disorders Infections and infestations: Common: nasopharyngitis, upper respiratory tract infection, sinusitis, influenza, gastroenteritis viral, urinary tract infection, bronchitis Uncommon: cellulitis, ear infection, gastroenteritis, pneumonia, viral infection General disorders: Common: fatigue, asthenia, malaise, weakness, pain, feeling hot, influenza like illness, fall, rigors, lethargy, pyrexia, chest pain, blood creatine phosphokinase increased, appetite decrease Uncommon: feeling jittery, edema lower limb, shivering, joint swelling, drug withdrawal syndrome, peripheral swelling, joint sprain, muscle injury, alanine aminotransferase increased, blood pressure increased, aspartate aminotransferase increased, heart rate increased, blood glucose increase, liver function tests abnormal Rare: weight loss, allergic reactions (e.g. dyspnoea, bronchospasm, wheezing, angioneurotic oedema) and anaphylaxis; Symptoms of withdrawal reactions, similar to those occurring during opiate withdrawal, may occur as follows: agitation, anxiety, nervousness, insomnia, hyperkinesia, tremor and gastrointestinal symptoms. Other symptoms that have very rarely been seen with tramadol discontinuation include: panic attacks, severe anxiety, hallucinations, paraesthesias, tinnitus and unusual CNS symptoms (i.e. confusion, delusions, depersonalization, derealization, paranoia) Not known: accidental injury, death, serotonin syndrome, flushing, hypoglycaemia Other adverse experiences, causal relationship unknown: A variety of other adverse events were reported infrequently in patients taking tramadol during clinical trials and/or reported in post-marketing experience. A causal relationship between Tramadol and these events has not been determined. Aabnormal ECG, hypotension, myocardial ischemia, pulmonary edema, pulmonary embolism, migraine, gastrointestinal bleeding, liver failure, proteinuria, hepatitis, stomatitis, Creatinine increase, hemoglobin decrease, cataracts, deafness
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
01/01/2000
הגבלות
תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת
מידע נוסף
עלון מידע לרופא
07.09.14 - עלון לרופאעלון מידע לצרכן
28.02.22 - עלון לצרכן אנגלית 08.06.22 - עלון לצרכן עברית 28.02.22 - עלון לצרכן ערבית 17.11.22 - עלון לצרכן אנגלית 17.11.22 - עלון לצרכן עברית 17.11.22 - עלון לצרכן ערבית 27.02.23 - עלון לצרכן עברית 28.08.23 - עלון לצרכן אנגלית 28.08.23 - עלון לצרכן ערבית 25.01.24 - עלון לצרכן עברית 22.05.24 - עלון לצרכן אנגלית 22.05.24 - עלון לצרכן עברית 22.05.24 - עלון לצרכן ערבית 15.11.12 - החמרה לעלון 03.04.14 - החמרה לעלון 26.08.14 - החמרה לעלון 25.04.21 - החמרה לעלון 28.02.22 - החמרה לעלון 08.06.22 - החמרה לעלון 03.02.19 - החמרה לעלון 20.06.19 - החמרה לעלון 27.02.23 - החמרה לעלון 25.01.24 - החמרה לעלוןלתרופה במאגר משרד הבריאות
טרמדקס טבליות